Attached files
| file | filename |
|---|---|
| 10-Q - 10-Q - PERNIX THERAPEUTICS HOLDINGS, INC. | body10q.htm |
| EX-31.1 - CEO 302 CERTIFICATE - PERNIX THERAPEUTICS HOLDINGS, INC. | exh31-1.htm |
| EX-31.2 - CFO 302 CERTIFICATE - PERNIX THERAPEUTICS HOLDINGS, INC. | exh31-2.htm |
EXHIBIT 32.1
CERTIFICATION UNDER SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, each of the undersigned certifies that this periodic report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and that information contained in this periodic report fairly presents, in all material respects, the financial condition and results of operations of Pernix Therapeutics Holdings, Inc. for the periods covered by this periodic report.
|
Date: May 5, 2016 |
|
/s/ DOUGLAS L. DRYSDALE |
|
|
|
|
Douglas L. Drysdale |
|
|
|
|
Chairman and Chief Executive Officer and President and Director |
|
|
|
|
|
|
|
Date: May 5, 2016 |
|
/s/ SANJAY S. PATEL |
|
|
|
|
Sanjay S. Patel |
|
|
|
|
(Principal Financial Officer) |
|